Page 132 - அரிசோனா துறை ஆஃப் ஆரோக்கியம் சேவைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail PHOENIX, Ariz. April 13, 2021 Findings of a study by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest that increasing expression of a gene known as ABCC1 could not only reduce the deposition of a hard plaque in the brain that leads to Alzheimer s disease, but might also prevent or delay this memory-robbing disease from developing. ABCC1, also known as MRP1, has previously been shown in laboratory models to remove a plaque-forming protein known as amyloid beta (Abeta) from specialized endothelial cells that surround and protect the brain and cerebral spinal cord. Building on previous studies, TGen conducted a series of pre-clinical genomic laboratory experiments. Results suggest that ABCC1 not only could export Abeta out of the brain, but that increasing the expression of ABCC1 could reduce Abeta production, thus preventing, or delaying, the onset of Alzheimer s.

United statesTodd levineSteve yozwiakMatt huentelmanWayne jepsenArizona alzheimer consortiumArizona department of health servicesTranslational genomics research institute tgenTgen neurogenomics divisionTgen foundationTranslational genomics research institutePostdoctoral fellowNeurogenomics divisionArizona departmentHealth servicesArizona alzheimer